Kymera Therapeutics remains focused on pipeline progression despite a Q4 revenue miss and widening net loss, supported by a robust $1.6 billion cash position. R&D investment surged to $316.6 million ...
Sepsis, a common complication following burns, trauma, and major surgery, remains the leading cause of death among critically ill patients. Globally, there are about 48.9 million sepsis patients and ...
BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company ...
Can you leave a clinical trial early? Learn your rights, what happens if you withdraw, and how to exit safely without affecting your medical care.
SAN ANTONIO, Texas, February 17, 2026--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung ...
SAN ANTONIO, Texas--(BUSINESS WIRE)--$BIAF #BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for ...
It is well known within the biopharma industry that clinical studies can produce any number of unexpected and possibly disappointing outcomes, including false negative results, or in statistical ...
Sichuan, China, Feb. 09, 2026 (GLOBE NEWSWIRE) -- In a notable case reflecting the evolving capabilities of restorative dentistry, Professor John A. Sorensen, DMD, PhD, FACP, of the University of ...
#7178 Case Study: uncommon clinical presentation of auto immune encephalitis in an adolescent female
1 MBBCh (Wits), MMed (Wits), FCPsych (SA), FCNeuropsych South Africa Definitive management for autoimmune encephalitis includes first-line immunotherapy (corticosteroids, intravenous immunoglobulins, ...
6 Health and Social Research Center, Universidad de Castilla La-Mancha, Cuenca, Spain Objective To examine the predictive validity of field-based muscular strength tests in relation to incident ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results